Mallinckrodt Plc - New Profit Margin

The latest profit margin for MNK is -38.9% as of March 2026. That compares with 86.91% in the prior-year period — down 144.8% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Mallinckrodt Plc - New's historical trend and sector peers before judging valuation or financial health.

Over the past year, MNK's profit margin moved from 86.91% to -38.9% — a 144.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mallinckrodt Plc - New's valuation or profitability profile.

Against Healthcare companies, MNK currently prints -38.9% for profit margin, while the sector average sits near 15.58%. That is roughly 349.6% below the sector mean. Large gaps often invite a closer look at Mallinckrodt Plc - New's growth, margins, and balance sheet.

Profit Margin shows how effectively Mallinckrodt Plc - New converts resources into returns. At -38.9%, MNK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 86.91% in the prior-year period — down 144.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MNK's profit margin (-38.9%), review year-over-year change from 86.91%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.